From Android to Workspace to custom chips, Google is quietly positioning Gemini to outperform ChatGPT. Here’s how its ...

In the agricultural sector, labor shortages are increasing the need for automated harvesting using robots. However, some fruits, like tomatoes, are tricky to harvest. Tomatoes typically bear fruit in ...

A treasure trove of deep reef dwellers has been discovered in coral reefs off the coast of Guam, including 20 that are new to ...

PDF files have become ubiquitous in our multi-platform world. This convenient file format makes it possible to view and share documents across various devices using various operating systems and ...

Since its release in 2009, it's been a continuing fallacy for pundits to hold up Mac OS X Snow Leopard as the perfect example of how Apple should update the Mac. It's a funny world where Apple is ...

Additive nanomanufacturing applies 3D printing at the nanoscale, enabling precise fabrication for electronics, energy, ...

In a useful entry in the growing canon of “quit lit,” Charles Knowles blends science and memoir to persuade readers to cut down on alcohol. By Alexandra Jacobs “People We Meet on Vacation,” “Wuthering ...

In “American Reich,” the former New York Times journalist Eric Lichtblau dissects the culture of hate that led to the death of a gay man in Southern California. By Elon Green A new graphic novel both ...

It’s that time of the year when PBS News Hour invites two of our regular literary critics, Ann Patchett and Maureen Corrigan, to highlight their favorite books of the year. Jeffrey Brown picks up the ...

The limited differences between the genomes of very different species have led to the emerging recognition that biological diversity is likely to largely derive from the complexity of RNA. This is ...

Google's Nano Banana Pro earned a near-perfect score. ChatGPT image ranked second; others often mangled text and faces. Nine tough prompts reveal which AIs are worth subscribing to. When generative AI ...

Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...